Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Zamtocabtagene autoleucel |
Synonyms | |
Therapy Description |
Zamtocabtagene autoleucel (MB-CART2019.1) are autologous T-lymphocytes engineered to express a chimeric antigen receptor (CAR) that targets both CD20 and CD19, potentially resulting in antitumor activity (Blood (2020) 136 (Supplement 1): 48). |